HR19042 / Jiangsu Hengrui Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HR19042 / Jiangsu Hengrui Pharma
NCT05476900: A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.

Recruiting
2
81
RoW
HR19042 Capsules
Jiangsu HengRui Medicine Co., Ltd.
Autoimmune Hepatitis
12/23
03/24
NCT05016323: A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.

Recruiting
2
210
RoW
HR19042 Capsules, Placebo
Jiangsu HengRui Medicine Co., Ltd.
IgA Nephropathy
02/24
05/24

Download Options